The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design

BACKGROUND: At present, diabetes is a chronic disease of great cost and heavy burdens. The International Diabetes Federation has repeatedly warned that by 2025, the global number of diabetics would rise to 333 million from 194 million in 2003. Although the occurrence of diabetes in developing countr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xiao, Guo, Liping, Shang, Hongcai, Ren, Ming, Wang, Yue, Huo, Da, Lei, Xiang, Wang, Hui, Zhai, Jingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632405/
https://www.ncbi.nlm.nih.gov/pubmed/26530718
http://dx.doi.org/10.1186/s13063-015-0990-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632405/
https://www.ncbi.nlm.nih.gov/pubmed/26530718
http://dx.doi.org/10.1186/s13063-015-0990-9

Ejemplares similares